Works matching AU Schwartz, Peter E.

Results: 81
    1

    Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes.

    Published in:
    2019
    By:
    • Feinberg, Jacqueline;
    • Albright, Benjamin;
    • Black, Jonathan;
    • Lu, Lingeng;
    • Passarelli, Rachel;
    • Gysler, Stefan;
    • Whicker, Margaret;
    • Altwerger, Gary;
    • Menderes, Gulden;
    • Hui, Pei;
    • Santin, Alessandro D.;
    • Azodi, Masoud;
    • Silasi, Dan-Arin;
    • Ratner, Elena S.;
    • Litkouhi, Babak;
    • Schwartz, Peter E.;
    • Santin, Alessandro D;
    • Ratner, Elena S;
    • Schwartz, Peter E
    Publication type:
    journal article
    2
    3
    4
    5
    6

    Allelic loss in ovarian cancer.

    Published in:
    International Journal of Cancer, 1993, v. 54, n. 4, p. 546, doi. 10.1002/ijc.2910540405
    By:
    • Yang-Feng, Teresa L.;
    • Han, Hong;
    • Chen, Kuang-Chao;
    • Li, Shi-Bo;
    • Claus, Elizabeth B.;
    • Carcangiu, Maria L.;
    • Chambers, Setsuko K.;
    • Chambers, Joseph T.;
    • Schwartz, Peter E.
    Publication type:
    Article
    7
    8
    9

    Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.

    Published in:
    BMC Cancer, 2011, v. 11, n. 1, p. 263, doi. 10.1186/1471-2407-11-263
    By:
    • Cocco, Emiliano;
    • Varughese, Joyce;
    • Buza, Natalia;
    • Bellone, Stefania;
    • Glasgow, Michelle;
    • Bellone, Marta;
    • Todeschini, Paola;
    • Carrara, Luisa;
    • Silasi, Dan-Arin;
    • Azodi, Masoud;
    • Schwartz, Peter E.;
    • Rutherford, Thomas J.;
    • Pecorelli, Sergio;
    • Lockwood, Charles J.;
    • Santin, Alessandro D.
    Publication type:
    Article
    10

    Clostridium perfringens enterotoxincarboxy-terminal fragment is a noveltumor-homing peptide for human ovarian cancer.

    Published in:
    BMC Cancer, 2010, v. 10, p. 349, doi. 10.1186/1471-2407-10-349
    By:
    • Cocco, Emiliano;
    • Casagrande, Francesca;
    • Bellone, Stefania;
    • Richter, Christine E.;
    • Bellone, Marta;
    • Todeschini, Paola;
    • Holmberg, Jennie C.;
    • Han Hsuan Fu;
    • Montagna, Michele K.;
    • Mor, Gil;
    • Schwartz, Peter E.;
    • Arin-Silasi, Dan;
    • Azoudi, Masoud;
    • Rutherford, Thomas J.;
    • Abu-Khalaf, Maysa;
    • Pecorelli, Sergio;
    • Santin, Alessandro D.
    Publication type:
    Article
    11
    12

    Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 12, p. 2449, doi. 10.1007/s00432-018-2753-y
    By:
    • Altwerger, Gary;
    • Florsheim, Esther B.;
    • Menderes, Gulden;
    • Black, Jonathan;
    • Schwab, Carlton;
    • Gressel, Gregory M.;
    • Nelson, Wendelin K.;
    • Carusillo, Nina;
    • Passante, Terri;
    • Huang, Gloria;
    • Litkouhi, Babak;
    • Azodi, Masoud;
    • Silasi, Dan-Arin;
    • Santin, Alessandro;
    • Schwartz, Peter E.;
    • Ratner, Elena S.
    Publication type:
    Article
    13
    14
    15

    Effect of exercise on body composition among women with ovarian cancer.

    Published in:
    Journal of Cancer Survivorship, 2023, v. 17, n. 5, p. 1386, doi. 10.1007/s11764-022-01207-x
    By:
    • Cao, Anlan;
    • Cartmel, Brenda;
    • Li, Fang-Yong;
    • Gottlieb, Linda T.;
    • Harrigan, Maura;
    • Ligibel, Jennifer A.;
    • Gogoi, Radhika;
    • Schwartz, Peter E.;
    • Irwin, Melinda L.;
    • Ferrucci, Leah M.
    Publication type:
    Article
    16
    17
    18

    Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 11, p. 1817, doi. 10.1002/cncr.29254
    By:
    • Abu‐Khalaf, Maysa M.;
    • Baumgart, Megan A.;
    • Gettinger, Scott N.;
    • Doddamane, Indukala;
    • Tuck, David P.;
    • Hou, Shihe;
    • Chen, Nianhang;
    • Sullivan, Catherine;
    • Lezon‐Geyda, Kimberly;
    • Zelterman, Daniel;
    • Hatzis, Christos;
    • Deshpande, Hari;
    • Digiovanna, Michael P.;
    • Azodi, Masoud;
    • Schwartz, Peter E.;
    • Harris, Lyndsay N.
    Publication type:
    Article
    19

    Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 3, p. 403, doi. 10.1002/cncr.29062
    By:
    • English, Diana P.;
    • Bellone, Stefania;
    • Schwab, Carlton L.;
    • Roque, Dana M.;
    • Lopez, Salvatore;
    • Bortolomai, Ileana;
    • Cocco, Emiliano;
    • Bonazzoli, Elena;
    • Chatterjee, Sudeshna;
    • Ratner, Elena;
    • Silasi, Dan‐Arin;
    • Azodi, Masoud;
    • Schwartz, Peter E.;
    • Rutherford, Thomas J.;
    • Santin, Alessandro D.
    Publication type:
    Article
    20
    21

    Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 14, p. 2582, doi. 10.1002/cncr.28017
    By:
    • Roque, Dana M.;
    • Bellone, Stefania;
    • English, Diana P.;
    • Buza, Natalia;
    • Cocco, Emiliano;
    • Gasparrini, Sara;
    • Bortolomai, Ileana;
    • Ratner, Elena;
    • Silasi, Dan‐Arin;
    • Azodi, Masoud;
    • Rutherford, Thomas J.;
    • Schwartz, Peter E.;
    • Santin, Alessandro D.
    Publication type:
    Article
    22

    Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin.

    Published in:
    Cancer (0008543X), 2011, v. 117, n. 24, p. 5519, doi. 10.1002/cncr.26215
    By:
    • Casagrande, Francesca;
    • Cocco, Emiliano;
    • Bellone, Stefania;
    • Richter, Christine E.;
    • Bellone, Marta;
    • Todeschini, Paola;
    • Siegel, Eric;
    • Varughese, Joyce;
    • Arin-Silasi, Dan;
    • Azodi, Masoud;
    • Rutherford, Thomas J.;
    • Pecorelli, Sergio;
    • Schwartz, Peter E.;
    • Santin, Alessandro D.
    Publication type:
    Article
    23

    Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody.

    Published in:
    2011
    By:
    • Varughese J;
    • Cocco E;
    • Bellone S;
    • de Leon M;
    • Bellone M;
    • Todeschini P;
    • Schwartz PE;
    • Rutherford TJ;
    • Pecorelli S;
    • Santin AD;
    • Varughese, Joyce;
    • Cocco, Emiliano;
    • Bellone, Stefania;
    • de Leon, Maria;
    • Bellone, Marta;
    • Todeschini, Paola;
    • Schwartz, Peter E;
    • Rutherford, Thomas J;
    • Pecorelli, Sergio;
    • Santin, Alessandro D
    Publication type:
    journal article
    24

    Serum amyloid A: a novel biomarker for endometrial cancer.

    Published in:
    2010
    By:
    • Cocco E;
    • Bellone S;
    • El-Sahwi K;
    • Cargnelutti M;
    • Buza N;
    • Tavassoli FA;
    • Schwartz PE;
    • Rutherford TJ;
    • Pecorelli S;
    • Santin AD;
    • Cocco, Emiliano;
    • Bellone, Stefania;
    • El-Sahwi, Karim;
    • Cargnelutti, Marilisa;
    • Buza, Natalia;
    • Tavassoli, Fattaneh A;
    • Schwartz, Peter E;
    • Rutherford, Thomas J;
    • Pecorelli, Sergio;
    • Santin, Alessandro D
    Publication type:
    journal article
    25

    Serum Amyloid A.

    Published in:
    Cancer (0008543X), 2010, v. 116, n. 4, p. 843, doi. 10.1002/cncr.24838
    By:
    • Cocco, Emiliano;
    • Bellone, Stefania;
    • El-Sahwi, Karim;
    • Cargnelutti, Marilisa;
    • Buza, Natalia;
    • Tavassoli, Fattaneh A.;
    • Schwartz, Peter E.;
    • Rutherford, Thomas J.;
    • Pecorelli, Sergio;
    • Santin, Alessandro D.
    Publication type:
    Article
    26

    Induction of Human Tumor-associated Differentially Expressed Gene-12 (TADG-12/TMPRSS3)-specific Cytotoxic T Lymphocytes in Human Lymphocyte Antigen-A2.1-positive Healthy Donors and Patients With Advanced Ovarian Cancer.

    Published in:
    Cancer (0008543X), 2009, v. 115, n. 4, p. 500, doi. 10.1002/cncr.24048
    By:
    • Bellone, Stefania;
    • Anfossi, Simone;
    • O'Brien, Timothy J.;
    • Cannon, Martin J.;
    • Silasi, Dan-Arm;
    • Azodi, Masoud;
    • Schwartz, Peter E.;
    • Rutherford, Thomas J.;
    • Pecorelli, Sergio;
    • Santin, Alessandro D.
    Publication type:
    Article
    27

    A CASE-CONTROL STUDY OF CANCER OF THE ENDOMETRIUM.

    Published in:
    American Journal of Epidemiology, 1982, v. 116, n. 2, p. 333, doi. 10.1093/oxfordjournals.aje.a113417
    By:
    • KELSEY, JENNWER L.;
    • LIVOLSI, VIRGINIA A.;
    • HOLFORD, THEODORE R;
    • FISCHER, DIANA B.;
    • MOSTOW, EVELYN D.;
    • SCHWARTZ, PETER E.;
    • O'CONNOR, THERESA;
    • WHITE, COLIN
    Publication type:
    Article
    28

    AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARY.

    Published in:
    American Journal of Epidemiology, 1981, v. 114, n. 3, p. 398, doi. 10.1093/oxfordjournals.aje.a113207
    By:
    • HILDRETH, NANCY G.;
    • KELSEY, JENNIFER L.;
    • LIVOLSI, VIRGINIA A.;
    • FISCHER, DIANA B.;
    • HOLFORD, THEODORE R.;
    • MOSTOW, EVELYN D.;
    • SCHWARTZ, PETER E.;
    • WHITE, COLIN
    Publication type:
    Article
    29
    30
    31

    Financial toxicity in patients with gynecologic malignancies: a cross sectional study.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 6, p. 1, doi. 10.3802/jgo.2021.32.e87
    By:
    • Zeybek, Burak;
    • Webster, Emily;
    • Pogosian, Natalia;
    • Tymon-Rosario, Joan;
    • Balch, Alan;
    • Altwerger, Gary;
    • Clark, Mitchell;
    • Menderes, Gulden;
    • Huang, Gloria;
    • Azodi, Masoud;
    • Ratner, Elena S.;
    • Schwartz, Peter E.;
    • Santin, Alessandro D.;
    • Andikyan, Vaagn
    Publication type:
    Article
    32
    33
    34
    35

    Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer.

    Published in:
    International Journal of Cancer, 2015, v. 137, n. 11, p. 2618, doi. 10.1002/ijc.29632
    By:
    • Cocco, Emiliano;
    • Shapiro, Erik M.;
    • Gasparrini, Sara;
    • Lopez, Salvatore;
    • Schwab, Carlton L.;
    • Bellone, Stefania;
    • Bortolomai, Ileana;
    • Sumi, Natalia J.;
    • Bonazzoli, Elena;
    • Nicoletti, Roberta;
    • Deng, Yang;
    • Saltzman, W. Mark;
    • Zeiss, Caroline J.;
    • Centritto, Floriana;
    • Black, Jonathan D.;
    • Silasi, Dan‐Arin;
    • Ratner, Elena;
    • Azodi, Masoud;
    • Rutherford, Thomas J.;
    • Schwartz, Peter E.
    Publication type:
    Article
    36
    37

    Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 9, p. 5597, doi. 10.1245/s10434-023-13757-0
    By:
    • Gelissen, Julia H.;
    • Adjei, Naomi N.;
    • McNamara, Blair;
    • Mutlu, Levent;
    • Harold, Justin A.;
    • Clark, Mitchell;
    • Altwerger, Gary;
    • Dottino, Peter R.;
    • Huang, Gloria S.;
    • Santin, Alessandro D.;
    • Azodi, Masoud;
    • Ratner, Elena;
    • Schwartz, Peter E.;
    • Andikyan, Vaagn
    Publication type:
    Article
    38
    39
    40
    41

    Psychosocial benefits of a cancer support group.

    Published in:
    1986
    By:
    • Cain, Eileen N.;
    • Kohorn, Ernest I.;
    • Quinlan, Donald M.;
    • Latimer, Kate;
    • Schwartz, Peter E.;
    • Cain, E N;
    • Kohorn, E I;
    • Quinlan, D M;
    • Latimer, K;
    • Schwartz, P E
    Publication type:
    journal article
    42
    43
    44

    Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer.

    Published in:
    Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00118
    By:
    • Perrone, Emanuele;
    • Lopez, Salvatore;
    • Zeybek, Burak;
    • Bellone, Stefania;
    • Bonazzoli, Elena;
    • Pelligra, Silvia;
    • Zammataro, Luca;
    • Manzano, Aranzazu;
    • Manara, Paola;
    • Bianchi, Anna;
    • Buza, Natalia;
    • Tymon-Rosario, Joan;
    • Altwerger, Gary;
    • Han, Chanhee;
    • Menderes, Gulden;
    • Ratner, Elena;
    • Silasi, Dan-Arin;
    • Azodi, Masoud;
    • Hui, Pei;
    • Schwartz, Peter E.
    Publication type:
    Article
    45
    46

    A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 6, p. 1206, doi. 10.1002/cncr.34025
    By:
    • Bellone, Stefania;
    • Roque, Dana M.;
    • Siegel, Eric R.;
    • Buza, Natalia;
    • Hui, Pei;
    • Bonazzoli, Elena;
    • Guglielmi, Adele;
    • Zammataro, Luca;
    • Nagarkatti, Nupur;
    • Zaidi, Samir;
    • Lee, Jungsoo;
    • Silasi, Dan‐Arin;
    • Huang, Gloria S.;
    • Andikyan, Vaagn;
    • Damast, Shari;
    • Clark, Mitchell;
    • Azodi, Masoud;
    • Schwartz, Peter E.;
    • Tymon‐Rosario, Joan R.;
    • Harold, Justin A.
    Publication type:
    Article
    47
    48

    Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2.

    Published in:
    Clinical & Experimental Metastasis, 2024, v. 41, n. 5, p. 765, doi. 10.1007/s10585-024-10297-z
    By:
    • Mutlu, Levent;
    • McNamara, Blair;
    • Bellone, Stefania;
    • Manavella, Diego D.;
    • Demirkiran, Cem;
    • Greenman, Michelle;
    • Verzosa, Miguel Skyler Z.;
    • Buza, Natalia;
    • Hui, Pei;
    • Hartwich, Tobias Max Philipp;
    • Harold, Justin;
    • Yang-Hartwich, Yang;
    • Zipponi, Margherita;
    • Altwerger, Gary;
    • Ratner, Elena;
    • Huang, Gloria S.;
    • Clark, Mitchell;
    • Andikyan, Vaagn;
    • Azodi, Masoud;
    • Schwartz, Peter E.
    Publication type:
    Article
    49
    50